Atox Bio For Profit
Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.It focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries. The company was founded in 2003 and headquartered in HaMerkaz, Israel.
Industry:
Clinical Data Management
Technology:
Participatory medicine
Funding Status:
Late Stage Venture
Investment Stage:
N/A
Estimated Revenue:
$5.0M
Headquarters:
Ness Ziona, HaMerkaz, Israel
Employee Number:
30
Number Of Exists:
N/A
Investor Type:
N/A
Founded Date:
2003